Emerging classes of protein-protein interaction inhibitors and new tools for their development

被引：134

作者：

Pagliaro, L ^{[1
]}

Felding, J ^{[1
]}

Audouze, K ^{[1
]}

Nielsen, SJ ^{[1
]}

Terry, RB ^{[1
]}

Krog-Jensen, C ^{[1
]}

Butcher, S ^{[1
]}

机构：

[1] Biomage AS, Copenhagen, Denmark

来源：

CURRENT OPINION IN CHEMICAL BIOLOGY | 2004年 / 8卷 / 04期

关键词：

D O I：

10.1016/j.cbpa.2004.06.006

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Protein-protein interactions play a key role in the signal transduction pathways that regulate cellular function. Three years ago, few descriptions of small molecule protein-protein interaction inhibitors (SMPPIIs) existed in the literature. Today, the number of examples of both the biology and chemistry of such interaction inhibitors is growing rapidly. This growth occurs at the convergence of medicinal chemistry, signaling biology and novel assay technology for profiling emerging compound classes and modes of action. Protein translocation assays provide a unique new tool for identifying, profiling, and optimizing SMPPIIs. This review summarizes recent work in the field, and outlines future developments we can anticipate.

引用

收藏

页码：442 / 449

页数：8

相关论文

共 54 条

[1] Nuclear export inhibitors and kinase inhibitors identified using a MAPK-activated protein kinase 2 Redistribution® screen [J].

Almholt, DLC ;

Loechel, F ;

Nielsen, SJ ;

Krog-Jensen, C ;

Terry, R ;

Bjorn, SP ;

Pedersen, HC ;

Præstegaard, M ;

Moller, S ;

Heide, M ;

Pagliaro, L ;

Mason, AJ ;

Butcher, S ;

Dahl, SW .

ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2004, 2 (01) :7-20

[2] Changes in intracellular cAMP reported by a Redistribution® assay using a cAMP-dependent protein kinase-green fluorescent protein chimera [J].

Almholt, K ;

Tullin, S ;

Skyggebjerg, O ;

Scudder, K ;

Thastrup, O ;

Terry, R .

CELLULAR SIGNALLING, 2004, 16 (08) :907-920

[3] Simultaneous visualization of the translocation of protein kinase Cα-green fluorescent protein hybrids and intracellular calcium concentrations [J].

Almholt, K ;

Arkhammar, POG ;

Thastrup, O ;

Tullin, S .

BIOCHEMICAL JOURNAL, 1999, 337 :211-218

[4]

AN J, 2003, IN PRESS J BIOL CHEM

[5] Protein-protein interactions as a target for drugs in proteomics [J].

Archakov, AI ;

Govorun, VM ;

Dubanov, AV ;

Ivanov, YD ;

Veselovsky, AV ;

Lewi, P ;

Janssen, P .

PROTEOMICS, 2003, 3 (04) :380-391

[6] Small-molecule inhibitors of protein-protein interactions: Progressing towards the dream [J].

Arkin, MR ;

Wells, JA .

NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (04) :301-317

[7] A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity [J].

Baba, M ;

Nishimura, O ;

Kanzaki, N ;

Okamoto, M ;

Sawada, H ;

Iizawa, Y ;

Shiraishi, M ;

Aramaki, Y ;

Okonogi, K ;

Ogawa, Y ;

Meguro, K ;

Fujino, M .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (10) :5698-5703

[8] Modulation of protein-protein interactions with small organic molecules [J].

Berg, T .

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2003, 42 (22) :2462-2481

[9] Small-molecule antagonists of Myc/Max dimerization inhibit Myc-induced transformation of chicken embryo fibroblasts [J].

Berg, T ;

Cohen, SB ;

Desharnais, J ;

Sonderegger, C ;

Maslyar, DJ ;

Goldberg, J ;

Boger, DL ;

Vogt, PK .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (06) :3830-3835

[10] Mechanistic studies with potent and selective inducible nitric-oxide synthase dimerization inhibitors [J].

Blasko, E ;

Glaser, CB ;

Devlin, JJ ;

Xia, W ;

Feldman, RI ;

Polokoff, MA ;

Phillips, GB ;

Whitlow, M ;

Auld, DS ;

McMillan, K ;

Ghosh, S ;

Stuehr, DJ ;

Parkinson, JF .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (01) :295-302

← 1 2 3 4 5 6 →